nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Warmth—Liotrix—hypothyroidism	0.0372	0.0484	CcSEcCtD
Zuclopenthixol—Menstruation irregular—Levothyroxine—hypothyroidism	0.0291	0.0378	CcSEcCtD
Zuclopenthixol—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.0291	0.0378	CcSEcCtD
Zuclopenthixol—HTR2A—cerebellar cortex—hypothyroidism	0.0266	0.12	CbGeAlD
Zuclopenthixol—DRD1—nerve—hypothyroidism	0.025	0.113	CbGeAlD
Zuclopenthixol—Menstruation irregular—Liotrix—hypothyroidism	0.0214	0.0278	CcSEcCtD
Zuclopenthixol—Feeling hot—Liotrix—hypothyroidism	0.0151	0.0196	CcSEcCtD
Zuclopenthixol—DRD2—nerve—hypothyroidism	0.0148	0.0667	CbGeAlD
Zuclopenthixol—Arrhythmia—Liothyronine—hypothyroidism	0.0147	0.0191	CcSEcCtD
Zuclopenthixol—HTR2A—urine—hypothyroidism	0.0141	0.0637	CbGeAlD
Zuclopenthixol—Hyperkinesia—Levothyroxine—hypothyroidism	0.014	0.0183	CcSEcCtD
Zuclopenthixol—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.014	0.0183	CcSEcCtD
Zuclopenthixol—CYP2D6—urine—hypothyroidism	0.0129	0.058	CbGeAlD
Zuclopenthixol—Increased appetite—Dextrothyroxine—hypothyroidism	0.0124	0.0162	CcSEcCtD
Zuclopenthixol—Increased appetite—Levothyroxine—hypothyroidism	0.0124	0.0162	CcSEcCtD
Zuclopenthixol—Hypertension—Liothyronine—hypothyroidism	0.0124	0.0161	CcSEcCtD
Zuclopenthixol—Tachycardia—Liothyronine—hypothyroidism	0.0114	0.0148	CcSEcCtD
Zuclopenthixol—Hypotension—Liothyronine—hypothyroidism	0.0109	0.0142	CcSEcCtD
Zuclopenthixol—Hyperkinesia—Liotrix—hypothyroidism	0.0103	0.0134	CcSEcCtD
Zuclopenthixol—Sweating increased—Dextrothyroxine—hypothyroidism	0.00983	0.0128	CcSEcCtD
Zuclopenthixol—Sweating increased—Levothyroxine—hypothyroidism	0.00983	0.0128	CcSEcCtD
Zuclopenthixol—HTR2A—nerve—hypothyroidism	0.00975	0.044	CbGeAlD
Zuclopenthixol—Body temperature increased—Liothyronine—hypothyroidism	0.00924	0.012	CcSEcCtD
Zuclopenthixol—Increased appetite—Liotrix—hypothyroidism	0.00914	0.0119	CcSEcCtD
Zuclopenthixol—Weight decreased—Dextrothyroxine—hypothyroidism	0.00913	0.0119	CcSEcCtD
Zuclopenthixol—Weight decreased—Levothyroxine—hypothyroidism	0.00913	0.0119	CcSEcCtD
Zuclopenthixol—Sweating—Levothyroxine—hypothyroidism	0.00863	0.0112	CcSEcCtD
Zuclopenthixol—Sweating—Dextrothyroxine—hypothyroidism	0.00863	0.0112	CcSEcCtD
Zuclopenthixol—DRD5—female gonad—hypothyroidism	0.00846	0.0382	CbGeAlD
Zuclopenthixol—Sweating increased—Liotrix—hypothyroidism	0.00723	0.00941	CcSEcCtD
Zuclopenthixol—Arrhythmia—Levothyroxine—hypothyroidism	0.00722	0.00939	CcSEcCtD
Zuclopenthixol—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00722	0.00939	CcSEcCtD
Zuclopenthixol—Tension—Levothyroxine—hypothyroidism	0.0069	0.00898	CcSEcCtD
Zuclopenthixol—Tension—Dextrothyroxine—hypothyroidism	0.0069	0.00898	CcSEcCtD
Zuclopenthixol—Nervousness—Levothyroxine—hypothyroidism	0.00683	0.00889	CcSEcCtD
Zuclopenthixol—Nervousness—Dextrothyroxine—hypothyroidism	0.00683	0.00889	CcSEcCtD
Zuclopenthixol—Weight decreased—Liotrix—hypothyroidism	0.00672	0.00874	CcSEcCtD
Zuclopenthixol—Tremor—Dextrothyroxine—hypothyroidism	0.00659	0.00857	CcSEcCtD
Zuclopenthixol—Tremor—Levothyroxine—hypothyroidism	0.00659	0.00857	CcSEcCtD
Zuclopenthixol—Agitation—Levothyroxine—hypothyroidism	0.00646	0.00841	CcSEcCtD
Zuclopenthixol—Agitation—Dextrothyroxine—hypothyroidism	0.00646	0.00841	CcSEcCtD
Zuclopenthixol—Sweating—Liotrix—hypothyroidism	0.00634	0.00826	CcSEcCtD
Zuclopenthixol—Palpitations—Dextrothyroxine—hypothyroidism	0.00621	0.00808	CcSEcCtD
Zuclopenthixol—Palpitations—Levothyroxine—hypothyroidism	0.00621	0.00808	CcSEcCtD
Zuclopenthixol—Convulsion—Dextrothyroxine—hypothyroidism	0.00609	0.00793	CcSEcCtD
Zuclopenthixol—Convulsion—Levothyroxine—hypothyroidism	0.00609	0.00793	CcSEcCtD
Zuclopenthixol—Anxiety—Dextrothyroxine—hypothyroidism	0.00597	0.00776	CcSEcCtD
Zuclopenthixol—Anxiety—Levothyroxine—hypothyroidism	0.00597	0.00776	CcSEcCtD
Zuclopenthixol—Shock—Levothyroxine—hypothyroidism	0.00565	0.00735	CcSEcCtD
Zuclopenthixol—Shock—Dextrothyroxine—hypothyroidism	0.00565	0.00735	CcSEcCtD
Zuclopenthixol—Tachycardia—Dextrothyroxine—hypothyroidism	0.0056	0.00729	CcSEcCtD
Zuclopenthixol—Tachycardia—Levothyroxine—hypothyroidism	0.0056	0.00729	CcSEcCtD
Zuclopenthixol—ADRA1A—heart—hypothyroidism	0.0056	0.0252	CbGeAlD
Zuclopenthixol—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00555	0.00722	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00555	0.00722	CcSEcCtD
Zuclopenthixol—Arrhythmia—Liotrix—hypothyroidism	0.00531	0.00691	CcSEcCtD
Zuclopenthixol—ADRA1A—cardiovascular system—hypothyroidism	0.00528	0.0238	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00523	0.0068	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00523	0.0068	CcSEcCtD
Zuclopenthixol—Insomnia—Dextrothyroxine—hypothyroidism	0.00519	0.00675	CcSEcCtD
Zuclopenthixol—Insomnia—Levothyroxine—hypothyroidism	0.00519	0.00675	CcSEcCtD
Zuclopenthixol—Dyspnoea—Levothyroxine—hypothyroidism	0.00512	0.00666	CcSEcCtD
Zuclopenthixol—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00512	0.00666	CcSEcCtD
Zuclopenthixol—Flatulence—Liotrix—hypothyroidism	0.0051	0.00663	CcSEcCtD
Zuclopenthixol—Tension—Liotrix—hypothyroidism	0.00508	0.0066	CcSEcCtD
Zuclopenthixol—Nervousness—Liotrix—hypothyroidism	0.00502	0.00654	CcSEcCtD
Zuclopenthixol—Fatigue—Dextrothyroxine—hypothyroidism	0.00495	0.00644	CcSEcCtD
Zuclopenthixol—Fatigue—Levothyroxine—hypothyroidism	0.00495	0.00644	CcSEcCtD
Zuclopenthixol—Vision blurred—Liotrix—hypothyroidism	0.00487	0.00634	CcSEcCtD
Zuclopenthixol—Tremor—Liotrix—hypothyroidism	0.00485	0.00631	CcSEcCtD
Zuclopenthixol—Agitation—Liotrix—hypothyroidism	0.00475	0.00618	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00473	0.00615	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Levothyroxine—hypothyroidism	0.00473	0.00615	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00469	0.00611	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00469	0.00611	CcSEcCtD
Zuclopenthixol—Syncope—Liotrix—hypothyroidism	0.00464	0.00604	CcSEcCtD
Zuclopenthixol—DRD2—pituitary gland—hypothyroidism	0.00458	0.0207	CbGeAlD
Zuclopenthixol—Palpitations—Liotrix—hypothyroidism	0.00457	0.00595	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Liotrix—hypothyroidism	0.00455	0.00591	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00454	0.0059	CcSEcCtD
Zuclopenthixol—Body temperature increased—Levothyroxine—hypothyroidism	0.00454	0.0059	CcSEcCtD
Zuclopenthixol—Abdominal pain—Levothyroxine—hypothyroidism	0.00454	0.0059	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00454	0.0059	CcSEcCtD
Zuclopenthixol—Convulsion—Liotrix—hypothyroidism	0.00448	0.00583	CcSEcCtD
Zuclopenthixol—Hypertension—Liotrix—hypothyroidism	0.00447	0.00581	CcSEcCtD
Zuclopenthixol—Anxiety—Liotrix—hypothyroidism	0.00439	0.00571	CcSEcCtD
Zuclopenthixol—ADRA2A—heart—hypothyroidism	0.00426	0.0192	CbGeAlD
Zuclopenthixol—Anaphylactic shock—Liotrix—hypothyroidism	0.00422	0.00549	CcSEcCtD
Zuclopenthixol—ADRA1A—adrenal gland—hypothyroidism	0.00418	0.0188	CbGeAlD
Zuclopenthixol—ADRA1A—blood—hypothyroidism	0.00418	0.0188	CbGeAlD
Zuclopenthixol—Shock—Liotrix—hypothyroidism	0.00415	0.0054	CcSEcCtD
Zuclopenthixol—Tachycardia—Liotrix—hypothyroidism	0.00412	0.00536	CcSEcCtD
Zuclopenthixol—Asthenia—Dextrothyroxine—hypothyroidism	0.00412	0.00536	CcSEcCtD
Zuclopenthixol—Asthenia—Levothyroxine—hypothyroidism	0.00412	0.00536	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Liotrix—hypothyroidism	0.00408	0.00531	CcSEcCtD
Zuclopenthixol—Pruritus—Levothyroxine—hypothyroidism	0.00406	0.00528	CcSEcCtD
Zuclopenthixol—Pruritus—Dextrothyroxine—hypothyroidism	0.00406	0.00528	CcSEcCtD
Zuclopenthixol—Anorexia—Liotrix—hypothyroidism	0.00402	0.00524	CcSEcCtD
Zuclopenthixol—Hypotension—Liotrix—hypothyroidism	0.00394	0.00513	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00393	0.00511	CcSEcCtD
Zuclopenthixol—Diarrhoea—Levothyroxine—hypothyroidism	0.00393	0.00511	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00385	0.005	CcSEcCtD
Zuclopenthixol—Insomnia—Liotrix—hypothyroidism	0.00382	0.00497	CcSEcCtD
Zuclopenthixol—Paraesthesia—Liotrix—hypothyroidism	0.00379	0.00493	CcSEcCtD
Zuclopenthixol—Dyspnoea—Liotrix—hypothyroidism	0.00376	0.0049	CcSEcCtD
Zuclopenthixol—Decreased appetite—Liotrix—hypothyroidism	0.00367	0.00477	CcSEcCtD
Zuclopenthixol—Vomiting—Levothyroxine—hypothyroidism	0.00365	0.00475	CcSEcCtD
Zuclopenthixol—Vomiting—Dextrothyroxine—hypothyroidism	0.00365	0.00475	CcSEcCtD
Zuclopenthixol—ADRA2A—gonad—hypothyroidism	0.00365	0.0164	CbGeAlD
Zuclopenthixol—Fatigue—Liotrix—hypothyroidism	0.00364	0.00474	CcSEcCtD
Zuclopenthixol—HTR2A—heart—hypothyroidism	0.00362	0.0163	CbGeAlD
Zuclopenthixol—Rash—Levothyroxine—hypothyroidism	0.00362	0.00471	CcSEcCtD
Zuclopenthixol—Rash—Dextrothyroxine—hypothyroidism	0.00362	0.00471	CcSEcCtD
Zuclopenthixol—Dermatitis—Levothyroxine—hypothyroidism	0.00361	0.0047	CcSEcCtD
Zuclopenthixol—Dermatitis—Dextrothyroxine—hypothyroidism	0.00361	0.0047	CcSEcCtD
Zuclopenthixol—Constipation—Liotrix—hypothyroidism	0.00361	0.0047	CcSEcCtD
Zuclopenthixol—Headache—Dextrothyroxine—hypothyroidism	0.00359	0.00468	CcSEcCtD
Zuclopenthixol—Headache—Levothyroxine—hypothyroidism	0.00359	0.00468	CcSEcCtD
Zuclopenthixol—ADRA2A—pituitary gland—hypothyroidism	0.00356	0.016	CbGeAlD
Zuclopenthixol—Feeling abnormal—Liotrix—hypothyroidism	0.00348	0.00453	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Liotrix—hypothyroidism	0.00345	0.00449	CcSEcCtD
Zuclopenthixol—HTR2A—cardiovascular system—hypothyroidism	0.00342	0.0154	CbGeAlD
Zuclopenthixol—Nausea—Dextrothyroxine—hypothyroidism	0.00341	0.00444	CcSEcCtD
Zuclopenthixol—Nausea—Levothyroxine—hypothyroidism	0.00341	0.00444	CcSEcCtD
Zuclopenthixol—DRD2—testis—hypothyroidism	0.00339	0.0153	CbGeAlD
Zuclopenthixol—Body temperature increased—Liotrix—hypothyroidism	0.00334	0.00434	CcSEcCtD
Zuclopenthixol—Abdominal pain—Liotrix—hypothyroidism	0.00334	0.00434	CcSEcCtD
Zuclopenthixol—ADRA1A—liver—hypothyroidism	0.00327	0.0147	CbGeAlD
Zuclopenthixol—HRH1—adrenal gland—hypothyroidism	0.00323	0.0146	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—hypothyroidism	0.00319	0.0144	CbGeAlD
Zuclopenthixol—ADRA2A—adrenal gland—hypothyroidism	0.00318	0.0143	CbGeAlD
Zuclopenthixol—ADRA2A—blood—hypothyroidism	0.00318	0.0143	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—hypothyroidism	0.00313	0.0141	CbGeAlD
Zuclopenthixol—Hypersensitivity—Liotrix—hypothyroidism	0.00311	0.00405	CcSEcCtD
Zuclopenthixol—HTR2A—gonad—hypothyroidism	0.0031	0.014	CbGeAlD
Zuclopenthixol—ADRA2A—thyroid gland—hypothyroidism	0.00307	0.0138	CbGeAlD
Zuclopenthixol—Asthenia—Liotrix—hypothyroidism	0.00303	0.00394	CcSEcCtD
Zuclopenthixol—HTR2A—pituitary gland—hypothyroidism	0.00302	0.0136	CbGeAlD
Zuclopenthixol—HRH1—female gonad—hypothyroidism	0.00302	0.0136	CbGeAlD
Zuclopenthixol—Pruritus—Liotrix—hypothyroidism	0.00299	0.00389	CcSEcCtD
Zuclopenthixol—ADRA2A—female gonad—hypothyroidism	0.00296	0.0134	CbGeAlD
Zuclopenthixol—Diarrhoea—Liotrix—hypothyroidism	0.00289	0.00376	CcSEcCtD
Zuclopenthixol—Dizziness—Liotrix—hypothyroidism	0.00279	0.00363	CcSEcCtD
Zuclopenthixol—HTR2A—adrenal gland—hypothyroidism	0.0027	0.0122	CbGeAlD
Zuclopenthixol—HTR2A—blood—hypothyroidism	0.0027	0.0122	CbGeAlD
Zuclopenthixol—Vomiting—Liotrix—hypothyroidism	0.00268	0.00349	CcSEcCtD
Zuclopenthixol—HRH1—testis—hypothyroidism	0.00267	0.0121	CbGeAlD
Zuclopenthixol—Rash—Liotrix—hypothyroidism	0.00266	0.00346	CcSEcCtD
Zuclopenthixol—Dermatitis—Liotrix—hypothyroidism	0.00266	0.00346	CcSEcCtD
Zuclopenthixol—Headache—Liotrix—hypothyroidism	0.00264	0.00344	CcSEcCtD
Zuclopenthixol—ADRA2A—testis—hypothyroidism	0.00263	0.0118	CbGeAlD
Zuclopenthixol—Nausea—Liotrix—hypothyroidism	0.00251	0.00326	CcSEcCtD
Zuclopenthixol—CYP2D6—blood—hypothyroidism	0.00246	0.0111	CbGeAlD
Zuclopenthixol—ADRA2A—cerebellum—hypothyroidism	0.00243	0.0109	CbGeAlD
Zuclopenthixol—CYP2D6—female gonad—hypothyroidism	0.00229	0.0103	CbGeAlD
Zuclopenthixol—HTR2A—testis—hypothyroidism	0.00223	0.0101	CbGeAlD
Zuclopenthixol—HTR2A—liver—hypothyroidism	0.00211	0.00953	CbGeAlD
Zuclopenthixol—HTR2A—cerebellum—hypothyroidism	0.00206	0.00931	CbGeAlD
Zuclopenthixol—CYP2D6—testis—hypothyroidism	0.00204	0.00918	CbGeAlD
Zuclopenthixol—CYP2D6—liver—hypothyroidism	0.00192	0.00868	CbGeAlD
Zuclopenthixol—CYP2D6—cerebellum—hypothyroidism	0.00188	0.00848	CbGeAlD
Zuclopenthixol—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	4.37e-05	0.00448	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—TRH—hypothyroidism	4.36e-05	0.00447	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	4.36e-05	0.00447	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—TSHB—hypothyroidism	4.28e-05	0.00438	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—TSHR—hypothyroidism	4.28e-05	0.00438	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	4.27e-05	0.00438	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.27e-05	0.00438	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—TRH—hypothyroidism	4.26e-05	0.00437	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—TRH—hypothyroidism	4.19e-05	0.0043	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—AVP—hypothyroidism	4.19e-05	0.00429	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—TRH—hypothyroidism	4.18e-05	0.00429	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	4.1e-05	0.00421	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	3.9e-05	0.004	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	3.9e-05	0.00399	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.89e-05	0.00399	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	3.89e-05	0.00399	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—TSHB—hypothyroidism	3.88e-05	0.00398	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—TSHR—hypothyroidism	3.88e-05	0.00398	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	3.82e-05	0.00392	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—TRH—hypothyroidism	3.81e-05	0.00391	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—TSHB—hypothyroidism	3.8e-05	0.00389	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—TSHR—hypothyroidism	3.8e-05	0.00389	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	3.74e-05	0.00383	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	3.74e-05	0.00383	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—TSHR—hypothyroidism	3.73e-05	0.00382	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—TSHB—hypothyroidism	3.73e-05	0.00382	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—TRH—hypothyroidism	3.7e-05	0.0038	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	3.66e-05	0.00375	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	3.66e-05	0.00375	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	3.61e-05	0.0037	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.46e-05	0.00355	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—AVP—hypothyroidism	3.44e-05	0.00353	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—TSHB—hypothyroidism	3.4e-05	0.00348	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	3.4e-05	0.00348	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TRH—hypothyroidism	3.36e-05	0.00345	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—IYD—hypothyroidism	3.33e-05	0.00341	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—TSHR—hypothyroidism	3.3e-05	0.00338	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—TSHB—hypothyroidism	3.3e-05	0.00338	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—TRH—hypothyroidism	3.19e-05	0.00327	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3e-05	0.00308	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TSHB—hypothyroidism	3e-05	0.00307	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TSHR—hypothyroidism	3e-05	0.00307	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CLTC—hypothyroidism	2.98e-05	0.00305	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—POMC—hypothyroidism	2.96e-05	0.00304	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—AVP—hypothyroidism	2.96e-05	0.00304	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.94e-05	0.00301	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TRH—hypothyroidism	2.9e-05	0.00297	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.89e-05	0.00296	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.89e-05	0.00296	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—TSHB—hypothyroidism	2.84e-05	0.00291	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—TSHR—hypothyroidism	2.84e-05	0.00291	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.83e-05	0.0029	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ATP5O—hypothyroidism	2.83e-05	0.0029	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—SH2B3—hypothyroidism	2.71e-05	0.00278	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—TPO—hypothyroidism	2.66e-05	0.00273	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.63e-05	0.0027	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—VAV3—hypothyroidism	2.62e-05	0.00268	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	2.59e-05	0.00265	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TSHB—hypothyroidism	2.58e-05	0.00265	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TSHR—hypothyroidism	2.58e-05	0.00265	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TRH—hypothyroidism	2.57e-05	0.00264	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—AVP—hypothyroidism	2.52e-05	0.00258	CbGpPWpGaD
Zuclopenthixol—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	2.46e-05	0.00252	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TRH—hypothyroidism	2.41e-05	0.00247	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—VAV3—hypothyroidism	2.38e-05	0.00244	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	2.37e-05	0.00243	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TRH—hypothyroidism	2.36e-05	0.00242	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	2.32e-05	0.00238	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CLTC—hypothyroidism	2.3e-05	0.00236	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TSHB—hypothyroidism	2.29e-05	0.00235	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TSHR—hypothyroidism	2.29e-05	0.00235	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AVP—hypothyroidism	2.29e-05	0.00235	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—POMC—hypothyroidism	2.29e-05	0.00235	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—AVP—hypothyroidism	2.24e-05	0.00229	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.22e-05	0.00228	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—AVP—hypothyroidism	2.2e-05	0.00226	CbGpPWpGaD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	2.2e-05	0.00225	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—AVP—hypothyroidism	2.2e-05	0.00225	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TRH—hypothyroidism	2.19e-05	0.00224	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—IYD—hypothyroidism	2.17e-05	0.00222	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	2.16e-05	0.00221	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	2.15e-05	0.00221	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TRH—hypothyroidism	2.15e-05	0.00221	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TRH—hypothyroidism	2.15e-05	0.0022	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	2.15e-05	0.0022	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	2.15e-05	0.0022	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	2.11e-05	0.00216	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	2.11e-05	0.00216	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	2.11e-05	0.00216	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	2.11e-05	0.00216	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	2.11e-05	0.00216	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	2.07e-05	0.00212	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	2.07e-05	0.00212	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SH2B3—hypothyroidism	2.05e-05	0.0021	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	2.02e-05	0.00207	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	2e-05	0.00205	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TRH—hypothyroidism	1.99e-05	0.00204	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CLTC—hypothyroidism	1.98e-05	0.00203	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—POMC—hypothyroidism	1.97e-05	0.00202	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	1.96e-05	0.00201	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.95e-05	0.002	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TSHB—hypothyroidism	1.95e-05	0.002	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TSHR—hypothyroidism	1.95e-05	0.002	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AVP—hypothyroidism	1.95e-05	0.00199	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	1.92e-05	0.00197	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TSHB—hypothyroidism	1.91e-05	0.00196	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TSHR—hypothyroidism	1.91e-05	0.00196	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.88e-05	0.00193	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	1.88e-05	0.00192	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	1.88e-05	0.00192	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—VAV3—hypothyroidism	1.86e-05	0.00191	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.84e-05	0.00189	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.84e-05	0.00189	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—VAV3—hypothyroidism	1.83e-05	0.00188	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TSHB—hypothyroidism	1.77e-05	0.00182	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TSHR—hypothyroidism	1.77e-05	0.00182	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AVP—hypothyroidism	1.77e-05	0.00181	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.75e-05	0.00179	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	1.74e-05	0.00179	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	1.74e-05	0.00179	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	1.74e-05	0.00178	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TPO—hypothyroidism	1.73e-05	0.00178	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TRH—hypothyroidism	1.71e-05	0.00175	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—POMC—hypothyroidism	1.68e-05	0.00172	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AVP—hypothyroidism	1.67e-05	0.00172	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—VAV3—hypothyroidism	1.58e-05	0.00162	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SH2B3—hypothyroidism	1.58e-05	0.00162	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TSHB—hypothyroidism	1.52e-05	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TSHR—hypothyroidism	1.52e-05	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—POMC—hypothyroidism	1.52e-05	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AVP—hypothyroidism	1.52e-05	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PRL—hypothyroidism	1.52e-05	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CLTC—hypothyroidism	1.49e-05	0.00153	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—POMC—hypothyroidism	1.49e-05	0.00152	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CLTC—hypothyroidism	1.47e-05	0.00151	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CLTC—hypothyroidism	1.47e-05	0.0015	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—POMC—hypothyroidism	1.46e-05	0.0015	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—POMC—hypothyroidism	1.46e-05	0.0015	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	1.44e-05	0.00148	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	1.43e-05	0.00147	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—VAV3—hypothyroidism	1.4e-05	0.00144	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SH2B3—hypothyroidism	1.36e-05	0.00139	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AVP—hypothyroidism	1.35e-05	0.00139	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	1.34e-05	0.00137	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	1.33e-05	0.00136	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	1.31e-05	0.00135	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—POMC—hypothyroidism	1.29e-05	0.00133	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	1.29e-05	0.00132	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TRH—hypothyroidism	1.29e-05	0.00132	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	1.29e-05	0.00132	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TRH—hypothyroidism	1.27e-05	0.0013	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TRH—hypothyroidism	1.27e-05	0.0013	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	1.26e-05	0.0013	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AVP—hypothyroidism	1.26e-05	0.0013	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	1.24e-05	0.00128	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TRH—hypothyroidism	1.24e-05	0.00128	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AVP—hypothyroidism	1.24e-05	0.00127	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—TSHB—hypothyroidism	1.23e-05	0.00126	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	1.22e-05	0.00125	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—VAV3—hypothyroidism	1.19e-05	0.00122	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	1.17e-05	0.0012	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—POMC—hypothyroidism	1.17e-05	0.0012	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	1.17e-05	0.0012	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PRL—hypothyroidism	1.17e-05	0.0012	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—VAV3—hypothyroidism	1.17e-05	0.0012	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TRH—hypothyroidism	1.16e-05	0.00119	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TSHB—hypothyroidism	1.15e-05	0.00118	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TSHR—hypothyroidism	1.15e-05	0.00118	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	1.15e-05	0.00118	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AVP—hypothyroidism	1.15e-05	0.00118	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IGF1—hypothyroidism	1.15e-05	0.00117	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TSHB—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TSHR—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TSHB—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TSHR—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AVP—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AVP—hypothyroidism	1.13e-05	0.00116	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—POMC—hypothyroidism	1.11e-05	0.00114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	1.11e-05	0.00114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	1.11e-05	0.00114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	1.11e-05	0.00113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	1.1e-05	0.00113	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VAV3—hypothyroidism	1.08e-05	0.00111	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	1.07e-05	0.00109	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AVP—hypothyroidism	1.04e-05	0.00107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	1.03e-05	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	1.03e-05	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	1.03e-05	0.00105	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SH2B3—hypothyroidism	1.03e-05	0.00105	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—POMC—hypothyroidism	1.01e-05	0.00104	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	1.01e-05	0.00103	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PRL—hypothyroidism	1.01e-05	0.00103	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SH2B3—hypothyroidism	1.01e-05	0.00103	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	9.88e-06	0.00101	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VAV3—hypothyroidism	9.33e-06	0.000956	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—SLC5A5—hypothyroidism	9.22e-06	0.000946	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	9.18e-06	0.000941	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—POMC—hypothyroidism	8.99e-06	0.000921	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AVP—hypothyroidism	8.99e-06	0.000921	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF1—hypothyroidism	8.64e-06	0.000886	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—POMC—hypothyroidism	8.4e-06	0.000861	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	8.27e-06	0.000848	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—hypothyroidism	8.25e-06	0.000846	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	8.1e-06	0.00083	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TSHB—hypothyroidism	8.03e-06	0.000823	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—hypothyroidism	7.63e-06	0.000782	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRL—hypothyroidism	7.61e-06	0.00078	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	7.52e-06	0.000771	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—hypothyroidism	7.51e-06	0.00077	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—hypothyroidism	7.49e-06	0.000768	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRL—hypothyroidism	7.49e-06	0.000768	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRL—hypothyroidism	7.47e-06	0.000766	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	7.35e-06	0.000754	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRL—hypothyroidism	7.33e-06	0.000752	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	7.16e-06	0.000734	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VAV3—hypothyroidism	7.04e-06	0.000722	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—hypothyroidism	6.94e-06	0.000711	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VAV3—hypothyroidism	6.93e-06	0.00071	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VAV3—hypothyroidism	6.91e-06	0.000709	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	6.83e-06	0.0007	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRL—hypothyroidism	6.81e-06	0.000698	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	6.78e-06	0.000695	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AVP—hypothyroidism	6.78e-06	0.000695	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AVP—hypothyroidism	6.67e-06	0.000684	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—hypothyroidism	6.67e-06	0.000684	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AVP—hypothyroidism	6.66e-06	0.000683	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AVP—hypothyroidism	6.54e-06	0.00067	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	6.3e-06	0.000646	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AVP—hypothyroidism	6.07e-06	0.000623	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SLC5A5—hypothyroidism	6.01e-06	0.000616	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—hypothyroidism	5.97e-06	0.000612	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—hypothyroidism	5.74e-06	0.000589	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—hypothyroidism	4.83e-06	0.000495	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—hypothyroidism	4.51e-06	0.000462	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—hypothyroidism	4.44e-06	0.000455	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—hypothyroidism	4.43e-06	0.000454	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—hypothyroidism	4.34e-06	0.000445	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—hypothyroidism	4.34e-06	0.000445	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—hypothyroidism	4.27e-06	0.000437	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—hypothyroidism	4.26e-06	0.000436	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	4.18e-06	0.000428	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—hypothyroidism	4.04e-06	0.000414	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	3.88e-06	0.000398	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—hypothyroidism	3.14e-06	0.000322	CbGpPWpGaD
